Bain Capital buys Mitsubishi Tanabe Pharma for $3.3bn
Pharmaceutical Technology
FEBRUARY 7, 2025
Bain Capital said its decision to buy Mitsubishi Tanabe is due to the strong growth potential of Japans healthcare industry.
Pharmaceutical Technology
FEBRUARY 7, 2025
Bain Capital said its decision to buy Mitsubishi Tanabe is due to the strong growth potential of Japans healthcare industry.
Bio Pharma Dive
FEBRUARY 10, 2025
The drug is cleared to treat complicated intra-abdominal infections, including those caused by tough-to-control, gram-negative bacteria.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
FEBRUARY 6, 2025
The biotech is evaluating several cystic fibrosis medicines that could either work alongside Vertex’s top-selling Trikafta or be used in new, multi-drug combinations.
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 5, 2025
(courtneyk/Getty Images) Research on the gut microbiome has triggered a ‘revolution‘ in nutritional science, and in the last few years, dietary fiber has become the “new protein” added to foods in abundance to feed our gut and boost our health. A recent study on mice, however, suggests not all fiber supplements are equally beneficial.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Rethinking Clinical Trials
FEBRUARY 12, 2025
In this Friday’s PCT Grand Rounds, Angelo Volandes of Dartmouth Health and James Tulsky of Dana-Farber Cancer Institute will present “A Cluster Randomized, Stepped-Wedge Pragmatic Trial to Enhance Goals-of-Care Communication for Older Adults With Cancer (ACP-PEACE).” The Grand Rounds session will be held on Friday, February 14, 2025, at 1:00 pm eastern.
Medical Xpress
FEBRUARY 7, 2025
Virginia Tech neuroscientists have uncovered a mitochondrial process that supports the brain cells critical for learning, memory, and social recognition.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 6, 2025
(Jack Atkinson/Unsplash) We know that spending lots of time sitting down isn’t good for us, but just how much exercise is needed to counteract the negative health effects of sitting down all day? Research suggests about 30-40 minutes per day of building up a sweat should do it.
Pharma Times
FEBRUARY 10, 2025
New methodology may boost innovation in protein engineering
Medical Xpress
FEBRUARY 8, 2025
Mitochondria are essential for generating energy that fuels cells and helps them function.
Bio Pharma Dive
FEBRUARY 6, 2025
Cobenfy, the main asset acquired through Bristol Myers’ $14 billion purchase of Karuna, had $10 million in sales in the fourth quarter and is around 1,000 prescriptions weekly by late January.
Pharmaceutical Technology
FEBRUARY 10, 2025
Tim Andrews underwent the procedure with the pig kidney as part of a three-person compassionate use study.
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 10, 2025
(Filipp Romanovski/Unsplash) If you look up at the sky on a clear day, you might notice little cobweb-like structures drifting across your field of vision.
Pharma Times
FEBRUARY 10, 2025
CSL Behring's study reveals significant long-term benefits
Medical Xpress
FEBRUARY 8, 2025
Pharmaceutical ads are difficult to avoid in American television programming and a growing number of them promote a class of medications called JAK inhibitors, using an acronym that assumes the average TV watcher knows exactly what JAK stands for.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Bio Pharma Dive
FEBRUARY 5, 2025
Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their use.
Pharmaceutical Technology
FEBRUARY 11, 2025
Novartis has agreed to acquire Anthos Therapeutics, a Boston-based clinical-stage biopharmaceutical company, for an upfront payment of $925m.
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 11, 2025
(koto_feja/E+/Getty Images) A new model of Alzheimer’s disease has been proposed, which could speed up efforts to understand and cure the complex condition while bringing all manifestations of the condition under one unifying theory.
Rethinking Clinical Trials
FEBRUARY 6, 2025
Speakers Richard L. Skolasky, ScD Professor, Johns Hopkins School of Medicine Department of Orthopaedic Surgery Kevin H. McLaughlin, DPT Assistant Professor, Johns Hopkins School of Medicine Department of Physical Medicine and Rehabilitation Slides Keywords Back Pain; Rural Health; Telehealth Key Points Low back pain (LBP) is the most common cause of disability globally and in the U.S.
Medical Xpress
FEBRUARY 7, 2025
The U.S. winter virus season is in full force, and by one measure is the most intense in 15 years.
Bio Pharma Dive
FEBRUARY 10, 2025
Shares in the brain drug developer rose by more than 20% Monday on news of the deal, which will forestall Teva's generic copy of Auvelity from entering the U.S. market until at least 2038.
Pharmaceutical Technology
FEBRUARY 10, 2025
Controversy surrounded Him & Hers commercial, called Sick of the System, in the lead up to Americas biggest sporting event.
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 11, 2025
Indian pharmaceutical industry plays a crucial role in the global drug supply chain, particularly in the US. Yet India needs to develop strategies to mitigate the impact of USAID funding freeze for Indian pharma companies.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharma Times
FEBRUARY 5, 2025
Breast cancer therapy offers hope for patients at risk of recurrence
Medical Xpress
FEBRUARY 8, 2025
Years ago, a young patient's mother told Emily McCourt, MD, associate professor of ophthalmology at the University of Colorado School of Medicine, that she hadn't used a prescribed ointment to treat her baby's chemical corneal burn but instead used her own breast milk.
Bio Pharma Dive
FEBRUARY 5, 2025
CagriSema, which underperformed expectations in its first Phase 3 test, will be studied at different doses and for longer duration in the new trial.
Pharmaceutical Technology
FEBRUARY 11, 2025
The World Health Organization and St Jude Children's Research Hospital have kicked off a programme to distribute cancer medicines to LMICs.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
pharmaphorum
FEBRUARY 10, 2025
AbbVie has won FDA approval for Emblaveo, a new antibiotic to treat pathogens that pose serious public health threats.
Pharma Times
FEBRUARY 6, 2025
Designation follows promising preclinical data and FDA clearance
Medical Xpress
FEBRUARY 8, 2025
New research details the subcellular structures in neurons that enable signals to be transmitted from where they are received at specific sites on dendrites to the decision-making cell body located hundreds of micrometers away. The new research finds that the endoplasmic reticulum and the plasma membrane form contact sites where specialized molecules control the release of calcium, which regulates the signals sent along the dendrite to the soma.
Bio Pharma Dive
FEBRUARY 11, 2025
The acquisition of Anthos Therapeutics could be worth up to $3.1 billion and returns to Novartis a blood thinner it licensed to the Blackstone-backed startup six years ago.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Let's personalize your content